Why clinical trials are leaving the US—and Asia and Australia are welcoming them

BMJ 2026

View at publisher
Authors: Jennifer Lutz, Neha Bhatt, Flynn Murphy
DOI: 10.1136/bmj.s220
Cited by: 2
References: 2

Abstract

Disruption and uncertainty in the US are leading many clinical trials to consider other countries for participation. Jennifer Lutz, Neha Bhatt, and Flynn Murphy report on the changing landscape—and why some places are making a major play for trials fleeing the US

Fields of Study & Subjects

Ethics in Clinical Research Science Research and Medicine Biomedical Ethics and Regulation

Publication details

Journal / source
BMJ
Publisher
BMJ
Volume
392
Pages
s220–s220
Publication date
13 February 2026
Language
EN